Overview

Semaglutide in Adults With Type 1 Diabetes

Status:
Not yet recruiting

Trial end date:
2025-10-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the use of once weekly semaglutide injection in inadequately controlled obese adults with type 1 diabetes (T1D) using FDA-approved hybrid closed-loop therapies.

Phase:

Phase 2

Details

Lead Sponsor:

University of Colorado, Denver

Collaborator:

Juvenile Diabetes Research Foundation